Developer docs
API playgroundTry for free, no card

Search company profiles

CogniHealth

Full company profile

uuid00eg8dm

Namestring
CogniHealth
Legal namestring
CogniCheck Inc.
Websiteurl
cognihealth.ai
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Cogni, doing business as CogniCheck Inc. and headquartered at 280 Joseph Street in Kitchener, Ontario, is a brain health technology company that has built an end-to-end voice biomarker platform spanning consumer wellness monitoring to clinical cognitive screening. The company's technology stack centers on the proprietary CogniClassifier machine learning model, which analyzes voice and speech patterns from natural conversation to detect and classify cognitive changes including early-stage dementia, and is positioned as both an internal engine and an externally licensable asset for researchers and clinicians.

The product portfolio is organized across three tiers. Calista is the consumer flagship, delivered via simple inbound phone calls (no app, login, or download required) and supplemented by a mobile app, providing conversational cognitive check-ins, trend tracking, and brain exercises. CogniDashboard is the enterprise command center for healthcare providers, researchers, and care teams to dispatch calls, monitor results, view trends, and export data. CogniClassifier is the proprietary cognitive classification engine offered for licensing and API-based integration into third-party clinical and research workflows. The platform claims HIPAA and PIPEDA compliance and is marketed as multilingual and accessibility-focused.

Commercially, Cogni operates a hybrid go-to-market model. On the consumer side, Calista is offered as a subscription product with billing described as monthly, though pricing is not publicly disclosed. On the enterprise and research side, CogniClassifier and CogniDashboard are sold through direct enterprise sales, with inquiries captured through a dedicated contact form segmented into Investment, Partnership, Research, and Enterprise/B2B categories. Distribution reaches individual consumers through phone-call and app channels globally, while enterprise channels target healthcare providers, research institutions, and B2B partners without disclosed geographic restrictions. The company markets primarily through its website, social media presence (Facebook, Instagram, LinkedIn, X), and newsletter, with user testimonials serving as a key conversion asset at the top of the funnel.

Short descriptiontext

CogniHealth (CogniCheck Inc.) is a Kitchener, Ontario-based brain health company that builds voice biomarker AI to monitor cognitive wellness. It serves consumers via Calista (phone-based cognitive companion), and researchers, clinicians, and enterprise partners via CogniClassifier and CogniDashboard.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersKitchener, Canada
HQ citystring
Kitchener
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
voice biomarker analysis, cognitive health monitoring, brain wellness platform, conversational AI screening, dementia detection software
Industry1 code
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Digital Health Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Calista Consumer Subscription
TypeSubscription Recurring
Description

Consumer brain wellness subscription delivered via phone call or app. Users call Calista for cognitive monitoring and receive wellness insights after each conversation. Tracks cognitive trends over time through regular check-ins.

cogni.inc
2CogniClassifier Enterprise Licensing
TypeLicensing Royalties
Description

Licensing of proprietary cognitive classification engine to researchers, clinicians, and enterprise partners for integration into their cognitive screening workflows.

cogni.inc
3CogniDashboard Enterprise
TypeSubscription Recurring
Description

Command center platform for healthcare providers, researchers, and care teams to manage brain health monitoring at scale.

cogni.inc
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Calista Consumer - Phone/App
ModelSubscriptionBilling cadenceMonthly
Notes

Pricing not publicly disclosed. Contact form available for inquiries.

cogni.inc
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 3 records shown
1Calista
Description

Consumer brain wellness platform delivered by phone - a brain health companion that monitors cognitive wellness through natural conversation.

cogni.inc
+2 more records
Core offering1 text field

Cogni sells a voice-biomarker brain health platform built around three products. Calista is a consumer brain wellness companion accessible via simple phone call or mobile app that delivers cognitive check-ins, wellness reports, and brain exercises. CogniClassifier is a proprietary ML engine licensed to researchers, clinicians, and enterprise partners for voice-based detection and classification of cognitive disorders including early-stage dementia. CogniDashboard is an enterprise command centre for healthcare providers and care teams to dispatch calls, track cognitive wellness results, view trends, and export data for population-scale brain health monitoring.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Cognitive wellness monitoring accessible without technical barriers
Product overview1 text field

Cogni is a voice-first cognitive health platform offering three integrated products: Calista (consumer-facing brain wellness companion accessible via phone or app, using voice biomarker analysis for cognitive monitoring), CogniClassifier (proprietary ML engine for researchers and clinicians to detect cognitive disorders), and CogniDashboard (enterprise command centre for healthcare providers to manage cognitive care at scale). The products form an end-to-end platform from consumer monitoring to clinical decision support.

Product and service3 records
1Calista
CategoryConsumer cognitive wellness software
Description

Calista is a consumer brain wellness companion accessible via simple phone call or mobile app that uses voice biomarker analysis to monitor cognitive wellness, deliver personalized reports after each conversation, and provide brain exercises through engaging dialogue — designed for adults of all ages seeking accessible, no-download cognitive check-ins.

2CogniClassifier
CategoryEnterprise cognitive screening engine
Description

CogniClassifier is a proprietary machine learning model that analyzes voice biomarkers to detect and classify cognitive disorders, including early-stage dementia, sold to researchers, clinicians, and enterprise partners for integration into their cognitive screening workflows.

3CogniDashboard
CategoryEnterprise clinical management software
Description

CogniDashboard is a healthcare provider management platform that enables care teams to dispatch cognitive check-in calls, track patient cognitive wellness results, view longitudinal trends, and export data for population-scale brain health monitoring.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Digital cognitive assessment platform offering tablet- and app-based screening tools for early detection of dementia and other neurological conditions. Targets the same enterprise clinical and research customers as Cogni's CogniDashboard and CogniClassifier.

TypeEmerging player
Description

Consumer mental wellness and meditation subscription app targeting similar end users with brain/mental health outcomes. Adjacent rather than directly competitive, but competes for the same consumer wellness subscription wallet share.

TypeDirect peer
Description

Digital cognitive health company offering computerized cognitive assessments and lifestyle programs for memory decline. Overlaps with Cogni on early-detection screening and consumer/clinical positioning in cognitive wellness.

TypeDirect peer
Description

Voice-based cognitive biomarker platform analyzing speech to detect and monitor dementia and other cognitive conditions. Cogni's most direct competitor on the core technology axis — both build ML models on voice for cognitive screening and target pharma and clinical research customers.

TypeDirect peer
Description

Developer of the CANTAB digital cognitive assessment battery used in clinical trials and clinical practice worldwide. Competes directly with CogniClassifier for pharma trial and clinical research deployments, and acquired Winterlight Labs to add voice biomarkers.

TypeDirect peer
Description

AI-driven digital cognitive assessment platform using smartphone-based tests to predict Alzheimer's risk. Targets similar pharma, clinical, and research customers as CogniClassifier and competes on the same digital cognitive screening RFPs.

TypeBroad incumbent
Description

Large biopharmaceutical company commercializing Alzheimer's therapeutics (Leqembi) and actively investing in cognitive screening and diagnostics ecosystems. Represents both a potential enterprise customer and a competitive threat as it builds diagnostic adjacencies.

TypeDirect peer
Description

Digital cognitive testing platform used by clinicians and health systems for rapid cognitive assessment. Competes with Cogni in the same healthcare-provider channel for screening tools, though delivers via app/tablet rather than phone.

TypeBroad incumbent
Description

Global pharmaceutical company with major Alzheimer's pipeline assets (Kisunla) and a growing interest in digital cognitive screening for trial recruitment and patient monitoring. Adjacent enterprise buyer for Cogni's screening IP.

TypeDirect peer
Description

Voice biomarker platform analyzing short voice samples for mental and cognitive health conditions. Closely comparable on the voice-AI technology layer that underpins CogniClassifier and Calista.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CogniHealth

Digital Health Softwarecognihealth.ai

CogniHealth (CogniCheck Inc.) is a Kitchener, Ontario-based brain health company that builds voice biomarker AI to monitor cognitive wellness. It serves consumers via Calista (phone-based cognitive companion), and researchers, clinicians, and enterprise partners via CogniClassifier and CogniDashboard.

What CogniHealth does

Cogni, doing business as CogniCheck Inc. and headquartered at 280 Joseph Street in Kitchener, Ontario, is a brain health technology company that has built an end-to-end voice biomarker platform spanning consumer wellness monitoring to clinical cognitive screening. The company's technology stack centers on the proprietary CogniClassifier machine learning model, which analyzes voice and speech patterns from natural conversation to detect and classify cognitive changes including early-stage dementia, and is positioned as both an internal engine and an externally licensable asset for researchers and clinicians.

The product portfolio is organized across three tiers. Calista is the consumer flagship, delivered via simple inbound phone calls (no app, login, or download required) and supplemented by a mobile app, providing conversational cognitive check-ins, trend tracking, and brain exercises. CogniDashboard is the enterprise command center for healthcare providers, researchers, and care teams to dispatch calls, monitor results, view trends, and export data. CogniClassifier is the proprietary cognitive classification engine offered for licensing and API-based integration into third-party clinical and research workflows. The platform claims HIPAA and PIPEDA compliance and is marketed as multilingual and accessibility-focused.

Commercially, Cogni operates a hybrid go-to-market model. On the consumer side, Calista is offered as a subscription product with billing described as monthly, though pricing is not publicly disclosed. On the enterprise and research side, CogniClassifier and CogniDashboard are sold through direct enterprise sales, with inquiries captured through a dedicated contact form segmented into Investment, Partnership, Research, and Enterprise/B2B categories. Distribution reaches individual consumers through phone-call and app channels globally, while enterprise channels target healthcare providers, research institutions, and B2B partners without disclosed geographic restrictions. The company markets primarily through its website, social media presence (Facebook, Instagram, LinkedIn, X), and newsletter, with user testimonials serving as a key conversion asset at the top of the funnel.

CogniHealth firmographics

Firmographics
Name
CogniHealth
Legal name
CogniCheck Inc.
Website
https://cognihealth.ai
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
1–10 employees
Short description
CogniHealth (CogniCheck Inc.) is a Kitchener, Ontario-based brain health company that builds voice biomarker AI to monitor cognitive wellness. It serves consumers via Calista (phone-based cognitive companion), and researchers, clinicians, and enterprise partners via CogniClassifier and CogniDashboard.
Ownership category
akta.pro rank

CogniHealth industry classification

Industry
Product category
Digital Health Software
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Voice biomarker analysis
  • Cognitive health monitoring
  • Brain wellness platform
  • Conversational AI screening
  • Dementia detection software

Where CogniHealth is headquartered

Location

Headquarters

HQ city
Kitchener
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

CogniHealth business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Calista Consumer Subscription: Consumer brain wellness subscription delivered via phone call or app. Users call Calista for cognitive monitoring and receive wellness insights after each conversation. Tracks cognitive trends over time through regular check-ins.
  2. CogniClassifier Enterprise Licensing: Licensing of proprietary cognitive classification engine to researchers, clinicians, and enterprise partners for integration into their cognitive screening workflows.
  3. CogniDashboard Enterprise: Command center platform for healthcare providers, researchers, and care teams to manage brain health monitoring at scale.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyCalista Consumer - Phone/App

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

CogniHealth product offering

Product offering

Core offering

Cogni sells a voice-biomarker brain health platform built around three products. Calista is a consumer brain wellness companion accessible via simple phone call or mobile app that delivers cognitive check-ins, wellness reports, and brain exercises. CogniClassifier is a proprietary ML engine licensed to researchers, clinicians, and enterprise partners for voice-based detection and classification of cognitive disorders including early-stage dementia. CogniDashboard is an enterprise command centre for healthcare providers and care teams to dispatch calls, track cognitive wellness results, view trends, and export data for population-scale brain health monitoring.

Product overview

Cogni is a voice-first cognitive health platform offering three integrated products: Calista (consumer-facing brain wellness companion accessible via phone or app, using voice biomarker analysis for cognitive monitoring), CogniClassifier (proprietary ML engine for researchers and clinicians to detect cognitive disorders), and CogniDashboard (enterprise command centre for healthcare providers to manage cognitive care at scale). The products form an end-to-end platform from consumer monitoring to clinical decision support.

Differentiator

Problem solved

Functional benefit

Brands

  • Calista: Consumer brain wellness platform delivered by phone - a brain health companion that monitors cognitive wellness through natural conversation.
  • CogniClassifier
  • CogniDashboard

Products and services

  • Calista Calista is a consumer brain wellness companion accessible via simple phone call or mobile app that uses voice biomarker analysis to monitor cognitive wellness, deliver personalized reports after each conversation, and provide brain exercises through engaging dialogue — designed for adults of all ages seeking accessible, no-download cognitive check-ins.
  • CogniClassifier CogniClassifier is a proprietary machine learning model that analyzes voice biomarkers to detect and classify cognitive disorders, including early-stage dementia, sold to researchers, clinicians, and enterprise partners for integration into their cognitive screening workflows.
  • CogniDashboard CogniDashboard is a healthcare provider management platform that enables care teams to dispatch cognitive check-in calls, track patient cognitive wellness results, view longitudinal trends, and export data for population-scale brain health monitoring.

Quantifiable outcome

  • Cognitive wellness monitoring accessible without technical barriers

Companies that use CogniHealth

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

CogniHealth technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature4 records

CogniHealth partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

CogniHealth competitors and assessment

Company assessment

Direct peers

  • Linus Health: Digital cognitive assessment platform offering tablet- and app-based screening tools for early detection of dementia and other neurological conditions. Targets the same enterprise clinical and research customers as Cogni's CogniDashboard and CogniClassifier.
  • Neurotrack: Digital cognitive health company offering computerized cognitive assessments and lifestyle programs for memory decline. Overlaps with Cogni on early-detection screening and consumer/clinical positioning in cognitive wellness.
  • Winterlight Labs: Voice-based cognitive biomarker platform analyzing speech to detect and monitor dementia and other cognitive conditions. Cogni's most direct competitor on the core technology axis — both build ML models on voice for cognitive screening and target pharma and clinical research customers.
  • Cambridge Cognition: Developer of the CANTAB digital cognitive assessment battery used in clinical trials and clinical practice worldwide. Competes directly with CogniClassifier for pharma trial and clinical research deployments, and acquired Winterlight Labs to add voice biomarkers.
  • Altoida: AI-driven digital cognitive assessment platform using smartphone-based tests to predict Alzheimer's risk. Targets similar pharma, clinical, and research customers as CogniClassifier and competes on the same digital cognitive screening RFPs.
  • BrainCheck: Digital cognitive testing platform used by clinicians and health systems for rapid cognitive assessment. Competes with Cogni in the same healthcare-provider channel for screening tools, though delivers via app/tablet rather than phone.
  • Sonde Health: Voice biomarker platform analyzing short voice samples for mental and cognitive health conditions. Closely comparable on the voice-AI technology layer that underpins CogniClassifier and Calista.

Emerging players

  • Headspace: Consumer mental wellness and meditation subscription app targeting similar end users with brain/mental health outcomes. Adjacent rather than directly competitive, but competes for the same consumer wellness subscription wallet share.

Broad incumbents

  • Biogen: Large biopharmaceutical company commercializing Alzheimer's therapeutics (Leqembi) and actively investing in cognitive screening and diagnostics ecosystems. Represents both a potential enterprise customer and a competitive threat as it builds diagnostic adjacencies.
  • Eli Lilly: Global pharmaceutical company with major Alzheimer's pipeline assets (Kisunla) and a growing interest in digital cognitive screening for trial recruitment and patient monitoring. Adjacent enterprise buyer for Cogni's screening IP.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

CogniHealth social profiles

Digital presence

CogniHealth compliance and trust

Trust signal

Compliance2 records

CogniHealth financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CogniHealth leadership team

Management profile

Number of profiles

CogniHealth funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CogniHealth M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CogniHealth

What does CogniHealth do?

Cogni sells a voice-biomarker brain health platform built around three products. Calista is a consumer brain wellness companion accessible via simple phone call or mobile app that delivers cognitive check-ins, wellness reports, and brain exercises. CogniClassifier is a proprietary ML engine licensed to researchers, clinicians, and enterprise partners for voice-based detection and classification of cognitive disorders including early-stage dementia. CogniDashboard is an enterprise command centre for healthcare providers and care teams to dispatch calls, track cognitive wellness results, view trends, and export data for population-scale brain health monitoring.

Is CogniHealth a public or private company?

CogniHealth is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was CogniHealth founded?

CogniHealth was founded in 2024. It employs 1 to 10 people.

Where is CogniHealth based?

CogniHealth is headquartered in Kitchener, Canada, in the North America region.

How does CogniHealth make money?

Three revenue lines are on record. Calista Consumer Subscription is the primary driver. The others are cogniClassifier Enterprise Licensing and cogniDashboard Enterprise.

Who are CogniHealth's main competitors?

Direct peers on record are Linus Health, Neurotrack, Winterlight Labs, Cambridge Cognition, Altoida, BrainCheck and Sonde Health. Headspace is listed as an emerging player. Broad incumbents are Biogen and Eli Lilly.

Does CogniHealth have an API?

No public API is recorded for CogniHealth.

What industry is CogniHealth in?

CogniHealth's product category is Digital Health Software. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital). Its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales